Clinical trials recruiting in Ars-Laquenexy, France

Phase breakdown

Conditions recruiting in Ars-Laquenexy, France

Recruiting trials in Ars-Laquenexy, France

• Comparison of the Performance of the 2024 and 2017 McDonald Criteria for the Diagnosis of Multiple Sclerosis in Real Life
  NCT07492667 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
  NCT05879276 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
  NCT04020263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• The Fourth Left Atrial Appendage Occlusion Study
  NCT05963698 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Ars-Laquenexy, France?

5 recruiting trials have at least one study site in Ars-Laquenexy, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.